carbamazepine / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

21 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
carbamazepine / Generic mfg.
ACTRN12607000142437: Efficacy & Safety of Zonisamide in newly diagnosed partial epilepsy patients.

Not yet recruiting
3
582
 
Eisai Ltd, Pharmaceutical Research Associate Ltd.
Newly diagnosed partial epilepsy
 
 
NCT00236717: A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

Completed
3
865
US
Topiramate; Carbamazepine; Valproate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Epilepsy, Seizures
 
11/00
NCT00007670: Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.

Completed
3
720
US
Carbamazepine, Gabapentin, Lamotrigine
US Department of Veterans Affairs, Parke-Davis, Glaxo Wellcome
Seizures
 
03/03
NCT00150735: Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

Completed
3
580
Europe, RoW
LEVETIRACETAM
UCB Pharma
Generalized Epilepsy
07/05
07/05
NCT00150553: Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder

Completed
3
102
US
Extended-release carbamazepine
Validus Pharmaceuticals
Bipolar Disorder
 
10/05
NCT00150605: Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

Completed
3
50
US
Extended-release carbamazepine
Validus Pharmaceuticals
Bipolar Disorder
 
10/05
NCT00150787: Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

Completed
3
250
Europe, RoW
LEVETIRACETAM
UCB Pharma
Epilepsy, Tonic-clonic
11/05
11/05
NCT00175903 / 2004-001339-41: Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy

Completed
3
1701
Europe, RoW
Levetiracetam, Carbamazepine Controlled Release (CBZ-CR), Valproate Extended Release
UCB Pharma
Epilepsy
10/07
10/07
NCT00266630: Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Completed
3
139
Japan
olanzapine, LY170053, Zyprexa, lithium, valproate, carbamazepine
Eli Lilly and Company
Manic or Mixed Episode Associated With Bipolar I Disorder
05/09
05/09
EpIc, NCT00542802 / 2006-004355-38: Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis

Unknown status
3
630
Europe
Levetiracetam, Carbamazepine
Scienze Neurologiche Ospedaliere
Epileptic Seizures, Stroke
06/09
06/09
NCT00477295 / 2006-000156-40: A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy

Completed
3
583
Europe, RoW
Zonisamide, Zonegran, Carbamazepine
Eisai Inc.
Epilepsy
12/10
01/11
NCT00848549 / 2008-001159-23: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Completed
3
295
Europe, RoW
Zonisamide, Zonegran, Carbamazepine
Eisai Inc.
Epilepsy
06/11
11/11
VICTOR, NCT01375374 / 2010-022534-84: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

Terminated
3
11
Europe
Lacosamide, Vimpat, Levetiracetam, Keppra
UCB Pharma
Epilepsy, Partial
03/13
03/13
SP0993, NCT01243177 / 2010-019765-28: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Completed
3
888
Europe, Canada, Japan, US, RoW
Lacosamide, Vimpat®, Carbamazepine-Controlled Release, Tegretol® Retard Tablets 200 mg
UCB BIOSCIENCES GmbH, Eden Sarl
Epilepsy, Monotherapy
07/15
08/15
NCT01954121 / 2015-004586-84: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

Completed
3
436
RoW
Levetiracetam, Keppra, Carbamazepine, Tegretol
UCB Pharma SA
Epilepsy, Partial Seizures
09/15
09/15
2015-000388-15: Treatment of vestibular paroxysmia with carbamazepine Carbamazepin zur Therapie der Vestibularisparoxysmie

Ongoing
3
153
Europe
Capsule, hard, Timonil retard
University of the University of Munich, Bundesministerium für Bildung und Forschung
The main symptoms of vestibular paroxysmia are brief attacks of rotatory or postural vertigo lasting seconds to a few minutes with or without ear symptoms (tinnitus and hypoacusis). As in trigeminal neuralgia or hemifacial spasm, it is assumed that a neurovascular cross-compression of the eighth cranial nerve is the cause of the attacks. Patienten mit Vestibularisparoxysmei leiden unter Sekunden bis wenige Minuten andauernden Schwindelattacken, welche von Ohrsymptomen begleitet werden können. Es wird angenommen, dass die Erkrankung ähnlich wie die Trigeminusneuralgie durch einen Gefäß-Nerven-Kontakt (des achten Hirnnervens) hervorgerufen wird., The main symptoms of vestibular paroxysmia are brief attacks of vertigo lasting seconds to a few minutes, sometimes with ear symptoms. Patienten mit Vestibularisparoxysmie leiden unter sich wiederholenden Schwindelattacken, welche Sekunden bis wenige Minuten andauern und manchmal von Ohrsymptomen begleitet werden., Diseases [C] - Nervous System Diseases [C10]
 
 
NCT01465997 / 2010-021238-74: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Completed
3
551
Canada, Japan, US, Europe, RoW
Lacosamide, VIMPAT film-coated tablets, Carbamazepine-Controlled Release (CBZ-CR), Tegretol® Retard Tablets 200 mg
UCB BIOSCIENCES GmbH, Eden Sarl
Epilepsy, Monotherapy
01/17
01/17
NCT02374567: Pharmacovigilance in Gerontopsychiatric Patients

Terminated
3
407
Europe
Phenobarbital, Phenytoin, Carbamazepine, Oxcarbazepine, Valproic Acid, Lamotrigine, Topiramate, Gabapentin, Levetiracetam, Pregabalin, Lacosamide, Clonazepam, Biperiden, Levomepromazine, Fluphenazine, Perphenazine, Perazine, Thioridazine, Haloperidol, Melperone, Pipamperone, Bromperidol, Benperidol, Sertindole, Ziprasidone, Flupentixol, Chlorprothixene, Zuclopenthixol, Fluspirilene, Pimozide, Clozapine, Olanzapine, Quetiapine, Sulpiride, Tiapride, Amisulpride, Prothipendyl, Risperidone, Aripiprazole, Paliperidone, Diazepam, Oxazepam, Lorazepam, Bromazepam, Clobazam, Alprazolam, Hydroxyzine, Buspirone, Chloral Hydrate, Flurazepam, Nitrazepam, Triazolam, Lormetazepam, Temazepam, Midazolam, Brotizolam, Zopiclone, Zolpidem, Zaleplon, Melatonin, Clomethiazole, Diphenhydramine, Promethazine, Imipramine, Clomipramine, Opipramol, Trimipramine, Amitriptyline, Nortriptyline, Doxepin, Maprotiline, Amitriptyline oxide, Fluoxetine, Citalopram, Paroxetine, Sertraline, Fluvoxamine, Escitalopram, Tranylcypromine, Moclobemide, Mianserin, Trazodone, Mirtazapine, Bupropion, Venlafaxine, Reboxetine, Duloxetine, Agomelatine, Pyritinol, Piracetam, Donepezil, Rivastigmine, Galantamine, Memantine, Nicergoline, Acamprosate, Lithium
Hannover Medical School
Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety Disorders
06/17
06/17
ACTRN12624000420549: CARGo: Investigating the Efficacy of Carbamazepine for the treatment of gonorrhoea in women

Not yet recruiting
2/3
75
 
Gold Coast University Hospital, Gold Coast Hospital and Health Service
gonorrhoea
 
 
NCT00913107: Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

Completed
2/3
21
RoW
Lamictal®, Lamotrigine (generic name for Lamictal®), Carbamazepine (generic name for Tegretol®), Tegretol®
University of Malaya
Trigeminal Neuralgia
02/08
06/08
NCT00562861: Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram

Completed
2/3
119
US
citalopram + mood stabilizer, Celexa, placebo + mood stabilizer, lithium, lamotrigine, valproate, or carbamazepine
Tufts Medical Center, National Institute of Mental Health (NIMH)
Bipolar Disorder, Bipolar Depression
07/14
07/14

Download Options